gptkbp:instance_of
|
gptkb:drug
|
gptkbp:clinical_trial
|
efficacy studies
safety studies
|
gptkbp:contains
|
gptkb:ethinyl_estradiol
gptkb:levonorgestrel
|
gptkbp:contraindication
|
liver disease
certain cancers
history of blood clots
smoking over age 35
|
gptkbp:dosage_form
|
gptkb:tablet
0.02 mg ethinyl estradiol
0.1 mg levonorgestrel
|
gptkbp:duration
|
28 days
|
gptkbp:effective_date
|
gptkb:1999
|
gptkbp:form
|
generic version
brand name version
|
https://www.w3.org/2000/01/rdf-schema#label
|
Alesse 21
|
gptkbp:ingredients
|
gptkb:ethinyl_estradiol
gptkb:levonorgestrel
|
gptkbp:interacts_with
|
gptkb:St._John's_Wort
antibiotics
anticonvulsants
HIV medications
|
gptkbp:is_used_for
|
contraception
|
gptkbp:manager
|
oral
|
gptkbp:manufacturer
|
gptkb:physicist
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
gptkbp:packaging
|
blister pack
|
gptkbp:regulatory_compliance
|
FDA approved
TGA approved
Health Canada approved
|
gptkbp:requires
|
prescription only
|
gptkbp:scholarships
|
not for use during pregnancy
missed dose instructions
take at the same time daily
consult doctor for side effects
|
gptkbp:side_effect
|
headache
nausea
weight gain
breast tenderness
mood changes
|
gptkbp:storage
|
room temperature
|
gptkbp:bfsParent
|
gptkb:Alesse
|
gptkbp:bfsLayer
|
6
|